Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience

Purpose: The neoadjuvant use of pertuzumab and trastuzumab with chemotherapy improves the pathologic complete response (pCR) in early HER2+ breast cancer. The aim of this study was to determine the pCR rate obtained with dual HER2 blockade in routine clinical practice. The secondary and tertiary obj...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Pathol Oncol Res
Main Authors: Boér, Katalin, Kahán, Zsuzsanna, Landherr, László, Csőszi, Tibor, Máhr, Károly, Ruzsa, Ágnes, Horváth, Zsolt, Budai, Barna, Rubovszky, Gábor
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2021
Fag:
Society Journal Archive
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262177/
https://ncbi.nlm.nih.gov/pubmed/34257621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.1609785
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker